Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ATF2 |
| Upstream (Parents) |
|---|
| (<<) ATN1 → ATF2 |
| (<<) BZW1 → ATF2 |
| (<<) CPD → ATF2 |
| (<<) CRKL → ATF2 |
| (<<) E2F4 → ATF2 |
| (<<) GNA13 → ATF2 |
| (<<) LPIN1 → ATF2 |
| (<<) MCL1 → ATF2 |
| (<<) TGFB1 → ATF2 |
| Downstream (Children) |
|---|
| ATF2 → ARAF (>>) |
| ATF2 → ATP2A2 (>>) |
| ATF2 → B3GNT2 (>>) |
| ATF2 → BBC3 (>>) |
| ATF2 → CASP8 (>>) |
| ATF2 → DMPK (>>) |
| ATF2 → GSK3A (>>) |
| ATF2 → HMGCS1 (>>) |
| ATF2 → HSPA9 (>>) |
| ATF2 → KCNG1 (>>) |
| ATF2 → MAPK8 (>>) |
| ATF2 → PTEN (>>) |
| ATF2 → SMAD1 (>>) |
| ATF2 → TGFB2 (>>) |
| ATF2 → WNT7B (>>) |
